Zdrowie i gospodarka · 27/10/2017
FDA Announces Draft Guidance for Pediatric Gastroesophageal Reflux Disease Treatment
The FDA has released a draft guidance to help pharmaceutical companies develop effective treatments for gastroesophageal reflux disease in children, covering clinical presentation, study design, and dosing considerations.
Source: Federal Register — Food and Drug AdministrationOpen original release →